Tweets
- Tweets, current page.
- Tweets & replies
- Media
You blocked @ASCOPost
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @ASCOPost
-
Marleen Kok, MD, PhD, on Triple-Negative Breast Cancer: Results From the TONIC Trial http://www.ascopost.com/videos/2017-esmo-congress/marleen-kok-md-phd-on-triple-negative-breast-cancer-results-from-the-tonic-trial/ …
#ESMO17#bcsm#oncologypic.twitter.com/d5f7SuRq0OThanks. Twitter will use this to make your timeline better. Undo -
Manuel Hidalgo, MD, PhD, on Biliary Tract Cancer: PRODIGY 12-ACCORD 18 Trial Results http://www.ascopost.com/videos/2017-esmo-congress/manuel-hidalgo-md-phd-on-biliary-tract-cancer-results-from-the-prodigy-12-accord-18-trial/ …
#ESMO17#hpbcsm#oncologypic.twitter.com/62EgWC7QONThanks. Twitter will use this to make your timeline better. Undo -
Robert I. Haddad, MD, on Head and Neck Cancer: Results of the CheckMate 141 Trial http://www.ascopost.com/videos/2017-esmo-congress/robert-i-haddad-md-on-head-and-neck-cancer-results-of-the-checkmate-141-trial/ …
#hncsm#ESMO17#oncologypic.twitter.com/hdkrfr6OvpThanks. Twitter will use this to make your timeline better. Undo -
Jaafar Bennouna, MD, on Colorectal Cancer: Targeted Treatments and Chemotherapy http://www.ascopost.com/videos/2017-esmo-congress/jaafar-bennouna-md-on-colorectal-cancer-clinical-trial-findings-on-targeted-treatments-and-chemotherapy/ …
#crcsm#ESMO17#oncologypic.twitter.com/yamqoWZMb3Thanks. Twitter will use this to make your timeline better. Undo -
David A. Tuveson, MD, PhD, on Progress in Pancreatic Cancer: Expert Perspective http://www.ascopost.com/videos/2017-esmo-congress/david-a-tuveson-md-phd-on-progress-in-pancreatic-cancer-expert-perspective/ …
#pancsm#ESMO17#oncologypic.twitter.com/4vYOXzzSNeThanks. Twitter will use this to make your timeline better. Undo -
Sibylle Loibl, MD, PhD, on Metastatic Breast Cancer: Expert Perspective on CDK4 Inhibitors http://www.ascopost.com/videos/2017-esmo-congress/sibylle-loibl-md-phd-on-metastatic-breast-cancer-expert-perspective-on-cdk4-inhibitors/ …
#BCSM#ESMO17#oncologypic.twitter.com/hSObsm2tU8Thanks. Twitter will use this to make your timeline better. Undo -
Mansoor Mirza, MD: Ovarian Cancer Treatment and Quality of Life http://www.ascopost.com/videos/2017-esmo-congress/mansoor-mirza-md-ovarian-cancer-treatment-and-quality-of-life/ …
#gyncsm#ESMO17#oncologypic.twitter.com/W2YSEQL7M5Thanks. Twitter will use this to make your timeline better. Undo -
Non–Small Cell Lung Cancer: Emerging Concepts for Checkpoint Inhibitors http://www.ascopost.com/issues/september-10-2017/non-small-cell-lung-cancer-emerging-concepts-for-checkpoint-inhibitors/ …
#LCSM#oncologyThanks. Twitter will use this to make your timeline better. Undo -
‘Sidedness’ in Colon Cancer: Using the Data in the Clinic http://www.ascopost.com/issues/september-10-2017/sidedness-in-colon-cancer-using-the-data-in-the-clinic/ …
#crcsm#oncologyThanks. Twitter will use this to make your timeline better. Undo -
Dr Anthony D'Amico on Long-Term Follow-up of PIVOT Trial in Prostate Cancer http://www.ascopost.com/issues/september-10-2017/long-term-follow-up-of-pivot-argues-for-immediate-treatment-of-men-with-unfavorable-risk-and-possibly-high-volume-low-risk-prostate-cancer/ …
#PCSM#oncologypic.twitter.com/gbB0Peeo7YThanks. Twitter will use this to make your timeline better. Undo -
Multiple Myeloma: Researchers Are Digging Deeper Than Ever http://www.ascopost.com/issues/september-10-2017/multiple-myeloma-researchers-are-digging-deeper-than-ever/ …
#MMSMThanks. Twitter will use this to make your timeline better. Undo -
Targeted Treatments and Health-Related Quality of Life in Ovarian Cancer http://www.ascopost.com/issues/september-10-2017/targeted-treatments-and-health-related-quality-of-life-in-ovarian-cancer/ …
#gyncsm#oncologyThanks. Twitter will use this to make your timeline better. Undo -
Update on Hematopoietic Cell Transplant Includes New Data in HIV-Infected and Follicular Lymphoma Patients http://www.ascopost.com/issues/september-10-2017/update-on-hematopoietic-cell-transplant-includes-new-data-in-hiv-infected-and-follicular-lymphoma-patients/ …
#lymsmThanks. Twitter will use this to make your timeline better. Undo -
Thanks. Twitter will use this to make your timeline better. Undo
-
Reviewing
#PARPinhibitors and their role in#triplenegativebreastcancer (#TNBC) at#ESMO17 with Dr. Garber of@DanaFarberpic.twitter.com/paXBiJcofwThanks. Twitter will use this to make your timeline better. Undo -
Rounding up
#urothelialcarcinoma#RCC and other#genitourinarycancer findings from#ESMO17 with Toni Choueiri and Laurence Albigespic.twitter.com/uCJG2Pf2CmThanks. Twitter will use this to make your timeline better. Undo -
Effect of Salvage Surgery on Survival in Recurrence After Treatment of Rectal Cancer http://www.ascopost.com/News/57808
#crcsm#surgonc#oncologyThanks. Twitter will use this to make your timeline better. Undo -
Michael Staehler and Toni Choueiri on the
#SWITCHII and#SURTIME trials in#RCC#kidneycancer#ESMO17pic.twitter.com/S7pJ2yCiHdThanks. Twitter will use this to make your timeline better. Undo -
Michele Beau-Faller of
@institut_cancer on ultrasensitive detection of#EGFRT790M mutation by#dropletdigital PCR in#NSCLC#ESMO17pic.twitter.com/jhAkC1Vis3Thanks. Twitter will use this to make your timeline better. Undo -
Cristina Saura of
@vallhebron on the#LORELEItrial in#breastcancer :#letrozole plus#taselisib vs#placebo#ESMO17pic.twitter.com/v2gqvTHaA0Thanks. Twitter will use this to make your timeline better. Undo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.